Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes. Meador CB, Digumarthy SR, Yeap BY, Hung YP, et al. Clin Cancer Res 2025;31:25-34.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Meador CB, Digumarthy SR, Yeap BY, Hung YP, et al. Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes. Clin Cancer Res 2025;31:25-34.
PMID: 39470668